BridgeBio Pharma Inc $ 68.29 0.58 (0.86%)
Volume:
2,355
Avg Vol (1m):
651,034
Market Cap $:
8.38 Bil
Enterprise Value $:
8.20 Bil
P/E (TTM):
0.00
P/B:
49.27
Financial Strength | 4/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 1.47 | ||
Equity-to-Asset | 0.21 | ||
Debt-to-Equity | 2.95 | ||
Debt-to-EBITDA | -1.14 | ||
Altman Z-Score | 6.61 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -1939.45 | ||
Net Margin % | -1832.68 | ||
ROE % | -119.81 | ||
ROA % | -50.85 | ||
ROC (Joel Greenblatt) % | -2502.74 |
BBIO
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 49.27 | ||
PS Ratio | 367.15 | ||
EV-to-EBIT | -19.27 | ||
EV-to-EBITDA | -19.27 | ||
EV-to-Revenue | 373.85 | ||
Current Ratio | 9.85 | ||
Quick Ratio | 9.85 | ||
Days Payable | 1436.49 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 49.13 | ||
Earnings Yield (Greenblatt) % | -5.19 |